OVID – ovid therapeutics inc. (US:NASDAQ)
Stock Stats
News
Ovid Therapeutics (OVID) had its "outperform" rating reaffirmed by Wedbush. They now have a $7.00 price target on the stock.
Ovid Therapeutics Inc. (OVID) Discusses KCC2 Deep Dive and Pipeline Advances in CNS Disorders Transcript [Seeking Alpha]
Ovid Therapeutics (OVID) had its price target raised by HC Wainwright from $2.00 to $4.00. They now have a "buy" rating on the stock.
Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14
Ovid Therapeutics (OVID) had its "buy" rating reaffirmed by BTIG Research. They now have a $4.00 price target on the stock.
Form 4 Ovid Therapeutics Inc. For: Apr 07 Filed by: Fitzgerald Kevin Joseph
Form 4 Ovid Therapeutics Inc. For: Apr 07 Filed by: PAPADOPOULOS STELIOS
Form 4 Ovid Therapeutics Inc. For: Apr 07 Filed by: Friedman Bart
Form 4 Ovid Therapeutics Inc. For: Mar 23 Filed by: LEVIN JEREMY M
Form S-8 Ovid Therapeutics Inc.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.